GlycoCore Pharma S.r.l. was incorporated on October 14^th, 2021 as a spin-off of the innovative SME Jointherapeutics S.r.l., which was dedicated for years to research and development of technologies and polysaccharide products for the treatment of galectins-mediated inflammatory and fibrotic processes.